This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Medication adherence is a large and growing challenge for pharma companies, healthcareproviders and the patients they serve. In the U.S. Research shows that 20% of patients have failed to fill a script in the past, and one-third aren’t confident managing their illness.
The company and the European Medicines Agency warned European healthcareproviders to continue limiting new patient prescriptions until the shortages let up.
In a highly regulated industry, choosing the right keywords can determine whether your ads reach healthcare professionals, patients, or caregivers effectively. Unlike consumer brands that can use aggressive bidding strategies on high-volume keywords, pharma ads must navigate strict regulatory guidelines.
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives.
2 Key Factors to Consider When Choosing a Partner 3 Strategies for Evaluating Pharma Marketing Companies 4 Measuring Success and Building Long-Term Partnerships Why Partner with a Pharmaceutical Marketing Company? Regulatory and Compliance Knowledge Pharma marketing has unique rulesdoes the agency understand them?
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcareproviders (HCPs) and patients. For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. But what exactly is programmatic advertising?
Now, it has launched a similar platform for healthcareproviders. The new platform, called “Provider Mode,” is designed to help providers search for drug cost information while they are conducting appointments with their patients.
Definition: A prescription is a written order for a patient to receive a medication or treatment. It is typically written by a physician or other authorized healthcareprovider and given to the patient, who then takes it to a pharmacy to have it filled.
SUMMARY: The media loves to blame pharma companies for high healthcare costs, but unless we start to invest in healthy lifestyles, we’re headed for a healthcare crisis the likes of which we have never experienced. Forget the fact that prescription drugs only account for $.10 Aye, that’s the question!
Despite a slew of prescription options and widespread advertising pushes, most patients are sticking with over-the-counter (OTC) remedies rather than trying new preventive medications, according to Phreesia Life Sciences’ survey results collected from more than 4,000 patients checking in for their doctors’ appointments in July 2021.
Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available. However, only 32% of patients trust pharma-developed apps.
This means that primary, specialty, and acute care are integrated and that healthcareproviders work as a networked team to deliver the best-coordinated care. For example, treatment plans may require the contributions of pharmacists, behavioral health providers, social services, specialists, and more.
The Role of AI in CRM: Transforming Pharma Sales AI in CRM is revolutionizing the way pharmaceutical companies interact with healthcare professionals (HCPs), patients, and other stakeholders. This not only improves engagement but also positions the pharma company as a valuable partner in the healthcare ecosystem.
Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcareproviders. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Soaring patient numbers are stretching hospital capacity across the globe, forcing healthcareproviders and their partners to think laterally about how to meet the demand without doubling their resources. Breaking down the opportunities. There are two main dimensions through which digital health solutions can have a significant impact.
A Smarter Approach to Pharma Marketing Pharma marketing is evolving rapidly as artificial intelligence (AI) and analytics make it easier to interpret health datasuch as insurance claims, lab results, and patient recordswhile also leveraging engagement data to refine outreach strategies.
By introducing medication tracking to its existing iPhone Health app, Apple just did for prescription drug users what it did for anyone with a physical wallet or airplane boarding pass. including when to take each prescription drug ? The doctor will see you now. This scenario is no longer relegated to the distant future.
However, despite being one of the biggest markets in pharma, diabetes drugmakers have a hard time standing out in the crowded field, and many patients still aren’t confident in their ability to manage their disease. Patients are willing to explore new prescription therapies as well, but most are unaware of their available options.
Given their often niche content, pharma marketers must target smaller, more exclusive audiences to drive results while developing impactful creative. Instead of trying to find new sources of identity, pharma marketers don’t have to look far to replace audience-based targeting. Premium Placement Quality Allows Creative to Shine.
What makes a pharma brand stand out in todays noisy, regulated digital space? Digital transformation in pharma is accelerating. Patients, providers, and caregivers are seeking information and support online long before engaging with reps or clinicians. Its not just about having a website or running banner ads.
In recent years, pharma companies have invested heavily in their healthcareprovider (HCP) portals, along with other digital solutions, to account for the reduction in face-to-face time between reps and HCPs during and post-pandemic. But it doesn’t have to be this way. What is meant by an HCP portal?
My Experience on the Ground As someone who’s worked in pharma sales, I’ve seen how much influence reps have in underserved areas. By staying patient and genuinely investing in relationships with healthcareproviders, reps can become trusted partners in improving care.
The inability to “pull through” a prescription, despite healthcareprovider (HCP) field team engagement and educational efforts, stubbornly remains a top client concern after 15 years of working in the market access space. For pharma, it can sometimes feel like a situation beyond their control.
Marketing pharma has become a complex and competitive field, with companies vying for the attention of healthcareproviders (HCPs), patients, and regulators alike. Marketing pharma has become a complex and competitive field, with companies vying for the attention of healthcareproviders (HCPs), patients, and regulators alike.
While this sort of innovation might not be a surprise in the automotive category, its breadth of functional benefits for patients and healthcareproviders (HCPs) might be. Health systems are signing off on network-wide solutions that use AI companions to record conversations, compile EHR notes, and even order tests and prescriptions.
Traditionally, when pharma marketers and their strategy, creative, and media agencies develop marketing plans, investment recommendations tend to focus on HCPs, patients, and managed care. Pharma marketers have begun to respond to this shift by allocating more of their promotional budgets to the NP/PA community.
From influencing patient behavior to shaping the way healthcareproviders prescribe medications, these advertisements play a crucial role in the pharmaceutical industry. However, the effects of these advertisements are not always positive, as they can also lead to overdiagnosis, overtreatment, and higher healthcare costs.
For pharma and medical devices, AR, VR, and AI are rapidly accelerating drug discovery, manufacturing, and supply chain efficiencies. Patients living in remote regions could be seen by healthcare professionals without having to travel great distances, and access to care for disabled or elderly people could improve significantly.
Swoop Launched in September 2024, the Swoop HCP Pro Suite is revolutionizing how pharmaceutical marketers engage with healthcareproviders (HCPs). By tailoring messaging frequency and content to align with patient care journeys, marketers eliminate waste, improve engagement, and drive higher prescription lift.
In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 1435 (“Affordable Prescriptions for Patients Act of 2021”), [link] gov/bill/117th-congress/senate-bill/1435/text; H.R. Measuring and rating biosimilar access. Actavis, 570 U.S.
Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. How can we ensure that vital prescription information reaches patients when they need it? These strategies also reduce the burden on the HCP to look for patient support information.
Did you know that a well-trained pharmaceutical sales rep can be the driving force behind a healthcareprovider's decision-making process? It's the secret sauce to thriving in the pharma industry. Training focused heavily on face-to-face interactions, with an emphasis on building relationships with healthcareproviders.
Often, these moments are happening in the presence of their healthcareprovider (HCP), especially in-person at doctor’s offices. Then during the visit, healthcareproviders can utilize tools such as a 3D human anatomy app to help patients visualize their treatments and conditions.
Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcareproviders (HCPs). When patients feel a pharma brand is responsive to their needs and committed to improving their treatment experience, it reinforces that brand’s reputation as a partner in their healthcare journey.³
Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. When providers browse travel websites, they are likely thinking about—you guessed it—travel. How are they different?
Our analysis included prescription trends for antibiotics, steroids, vitamins and ophthalmic-intraocular pressure reducing agents (prostaglandin analogs and alpha-adrenergic agonists) from 2018 to 2021. Learn more about the Clarivate real world data offering here.
However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcareproviders (HCPs) as consumers. Patient access solutions, including hubs and specialty pharmacies, play a vital role in getting patients started on therapy.
As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. 2 The percentage of healthcareproviders willing to see pharmaceutical company reps in person had declined from 67% in 2018 to 54% in 2019. Fierce Healthcare.
In this issue, we take a closer look at the patient experience and how it is constantly evolving in the pharma industry. This integration allows patients to book appointments, access their medication history, and manage prescriptions all in one place, simplifying their experience.
For pharma sales reps, this shift changes the conversation. Meanwhile, generic reps focus on price and accessibility, making their pitch to healthcareproviders and patients alike. As someone in pharma sales, I see the impact this has on our market. Chances are, you can get the same treatment for much less.
While biologics only account for 2% of overall prescriptions, they contribute to 37% of net drug spending [1]. This can make these treatment options much less accessible to the general public as it forces many healthcare professionals and insurance companies to rule them out for cheaper, possibly inferior, formulations.
billion allocated to the Health Ministry, which may indicate an increase in funding and potential opportunities for partnerships or collaborations with healthcareproviders and organizations. The company also offers online prescriptions and delivery services for medications. Some notable items include: RM36.3
Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. Patients want to know other patients are involved in what pharma is doing. Learn how pharma is involving them. They want to hear about those patients’ experiences.
As healthcareproviders (HCPs) are re-deployed to care for COVID-19 patients, many chronically-ill patients will have less frequent follow-up with their doctors. Biopharma brand teams will need to adjust their expectations around product adoption in light of this new normal.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content